Showing results (31-40 of 252) with videos related to

Sort By:
Pageof 26
Cancer Biology & Therapy|January 17, 2004
Identification of novel survivin-derived CTL epitopesSine Reker, Anders Meier, Lars Holten-Andersen, et al.
Oncoimmunology|February 26, 2024
Arginase-1 specific CD8+ T cells react toward malignant and regulatory myeloid cellsHannah Jorinde Glöckner, Evelina Martinenaite, Thomas Landkildehus Lisle, et al.
Cancer Immunology, Immunotherapy : CII|October 29, 2010
Identification of a cyclin B1-derived CTL epitope eliciting spontaneous responses in both cancer patients and healthy donorsRikke Sick Andersen, Rikke Bæk Sørensen, Cathrin Ritter, et al.
The Journal of Investigative Dermatology|February 13, 2009
Melanoma inhibitor of apoptosis protein (ML-IAP) specific cytotoxic T lymphocytes cross-react with an epitope from the auto-antigen SS56Rikke Baek Sørensen, Mikkel Faurschou, Lone Troelsen, et al.
Stem Cell Investigation|January 13, 2017
Peptide vaccination against multiple myeloma using peptides derived from anti-apoptotic proteins: a phase I trialNicolai Grønne Jørgensen, Shamaila Munir Ahmad, Niels Abildgaard, et al.
Oncoimmunology|December 25, 2012
BRAF inhibition improves tumor recognition by the immune system: Potential implications for combinatorial therapies against melanoma involving adoptive T-cell transferMarco Donia, Paolo Fagone, Ferdinando Nicoletti, et al.
Cancer Immunology, Immunotherapy : CII|October 2, 2008
The immunodominant HLA-A2-restricted MART-1 epitope is not presented on the surface of many melanoma cell linesRikke Baek Sørensen, Niels Junker, Alexei Kirkin, et al.
Oncoimmunology|May 12, 2015
Spontaneous presence of FOXO3-specific T cells in cancer patientsStine Kiaer Larsen, Shamaila Munir Ahmad, Manja Idorn, et al.
Blood|September 16, 2004
Immunogenicity of Bcl-2 in patients with cancerMads Hald Andersen, Inge Marie Svane, Pia Kvistborg, et al.
The Journal of Investigative Dermatology|March 29, 2002
Differential expression of inhibitory or activating CD94/NKG2 subtypes on MART-1-reactive T cells in vitiligo versus melanoma: a case reportLars Østergaard Pedersen, Claudia S Vetter, Maria C Mingari, et al.
Pageof 26